HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Butorfanol tartrate (beforol) in cancer surgery].

Abstract
The results of the clinical study of beforal (butorfanol) ("Spofa", Czechoslovakia), a synthetic analgetic from a class of opiate agonists-antagonists, in 17 cancer patients at all stages of surgical treatment have been summarized. It has been established that beforal is a potent analgetic analogous in antistressor properties to moradol ("Galenika", Yugoslavia), however differing by a more prompt onset and discontinuation of action, thus improving the control over general anesthesia. A comparative assessment of circulation parameters and stress factors (glucose, cortisol, blood plasma STH) has shown that beforal exceeds fentanyl in the efficacy of prevention of surgical trauma during and after extended cancer surgery.
AuthorsN A Osipova, V V Petrova, M S Vetsheva, T V Dolgopolova, O V Novikova, E I Mozgovaia, N A Loseva
JournalAnesteziologiia i reanimatologiia (Anesteziol Reanimatol) 1993 Sep-Oct Issue 5 Pg. 8-12 ISSN: 0201-7563 [Print] Russia (Federation)
Vernacular TitleButorfanol tartrat (beforal) v onkokhirurgii.
PMID8116910 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Butorphanol
Topics
  • Adult
  • Aged
  • Analgesia
  • Butorphanol (therapeutic use)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasms (surgery)
  • Pain, Postoperative (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: